DocWire News Editors

DocwireNews

Iron overload has been identified as a common and important issue in the management of patients with myelodysplastic syndromes (MDS). To help clinicians diagnose and manage iron overload in patients with MDS, the Canadian Consortium on MDS (CCMDS) has developed a step-by-step algorithm, called the MDS Iron Road.
The tool is available free online and was presented at the 62nd ASH Annual Meeting &amp; Exposition. Lead author Heather A. Leitch, MD, of St. Paul’s Hospital University of British Columbia in Vancouver, Canada, and colleagues hope the algorithm will help standardize care for patients with MDS and iron overload.
The MDS Iron Road reviews:
<ul>
<li>Iron-reduction strategies, including iron chelation therapy (ICT)</li>
<li>Evidence supporting the clinical benefits of ICT</li>
<li>Chelators available</li>
<li>Dosing, administration, and adjustments</li>
<li>Monitoring guidance and expected response</li>
<li>Side effect management</li>
</ul>
Clinicians have two ways to use the tool. A self-directed Iron Road outlines the algorithm. The IR Express mode guides the user through a series of questions about a patient, then makes a treatment recommendation.
The tool offers evidence to support treatment recommendations when available. In areas where evidence was lacking, the consortium offers practical recommendations based on their clinical experience.
During the ASH meeting, the researchers presented a case study to demonstrate how the algorithm works at different decision points. They highlighted research that supports certain decisions, as well as areas where data are lacking that could benefit from future research.
The MDS Iron Road is based on years of work by the consortium. In 2008, the CCMDS published an evidence-based consensus guideline regarding the diagnosis, workup, and management of iron overload in patients with MDS. That guideline discusses cellular damage caused by iron overload, including organ dysfunction, infections, marrow failure, progression of acute myeloid leukemia, decreased survival, and more. Then, in 2013, the consortium released MDS Clear Path, an internet-based algorithm for the diagnosis, workup, and management of MDS. The latest addition to the consortium’s resources is the MDS Iron Road, which refers back to the MDS Clear Path as needed, such as for prognostic scores and details on therapeutic options.
The tool is available online at <a href="http://www.mdsironroad.org">www.mdsironroad.org</a>. The username is ironroad, and the password is makeirongreatagain. It is currently in English, with a French version in development.
Although the MDS Iron Road includes treatment options that may not be currently approved in all geographic areas, the researchers said the algorithm will be updated to reflect future approvals and advances.

Emily Menendez

Complete Response to Immunotherapy in HCC: Insights From IMbrave150

Hepatocellular Carcinoma

Anne Marie Morse, DO

Rob Dillard

Dr. Morse Talks About the Significance of World Sleep Day 2025

Sleep Disorders

Dr. John Fruehauf, Evolent

Advancing Therapies Have Improved the Prognosis of Metastatic Melanoma

Melanoma

Latest News

Tool to Manage Iron Overload in Patients with Myelodysplastic Syndromes

ASH Annual Meeting 2020

Iron overload has been identified as a common and important issue in the management of patients with myelodysplastic syndromes (MDS). To help clinicians diagnose and manage ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe